Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Haruji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.
Guangdong Marubi Biotechnology Co (603983) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.013x
Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) has a cash flow conversion efficiency ratio of 0.013x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.25 Million) by net assets (CN¥3.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangdong Marubi Biotechnology Co - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Guangdong Marubi Biotechnology Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guangdong Marubi Biotechnology Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangdong Marubi Biotechnology Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Claros Mortgage Trust Inc
NYSE:CMTG
|
0.005x |
|
Signature Bank
PINK:SBNYL
|
0.011x |
|
Yduqs Participações S.A
SA:YDUQ3
|
0.165x |
|
Hap Seng Consolidated Bhd
KLSE:3034
|
0.034x |
|
J&V Energy Tech Co Ltd
TW:6869
|
-0.037x |
|
Shenzhen King Explorer Science and Technology Corp Class A
SHE:002917
|
0.035x |
|
Newgen Software Technologies Limited
NSE:NEWGEN
|
0.056x |
|
Jiangsu New Energy Development Co Ltd
SHG:603693
|
0.063x |
Annual Cash Flow Conversion Efficiency for Guangdong Marubi Biotechnology Co (2011–2024)
The table below shows the annual cash flow conversion efficiency of Guangdong Marubi Biotechnology Co from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.45 Billion | CN¥300.53 Million | 0.087x | -11.81% |
| 2023-12-31 | CN¥3.42 Billion | CN¥338.02 Million | 0.099x | +564.00% |
| 2022-12-31 | CN¥3.25 Billion | CN¥48.44 Million | 0.015x | +728.75% |
| 2021-12-31 | CN¥3.16 Billion | CN¥-7.48 Million | -0.002x | -101.96% |
| 2020-12-31 | CN¥3.00 Billion | CN¥362.35 Million | 0.121x | -30.74% |
| 2019-12-31 | CN¥2.67 Billion | CN¥465.53 Million | 0.174x | -53.37% |
| 2018-12-31 | CN¥1.38 Billion | CN¥516.69 Million | 0.374x | +0.77% |
| 2017-12-31 | CN¥959.96 Million | CN¥356.20 Million | 0.371x | +44.03% |
| 2016-12-31 | CN¥828.09 Million | CN¥213.33 Million | 0.258x | -32.96% |
| 2015-12-31 | CN¥715.92 Million | CN¥275.11 Million | 0.384x | -38.26% |
| 2014-12-31 | CN¥604.48 Million | CN¥376.24 Million | 0.622x | -13.40% |
| 2013-12-31 | CN¥453.11 Million | CN¥325.67 Million | 0.719x | -25.79% |
| 2012-12-31 | CN¥234.87 Million | CN¥227.49 Million | 0.969x | -46.78% |
| 2011-12-31 | CN¥148.02 Million | CN¥269.39 Million | 1.820x | -- |